204 related articles for article (PubMed ID: 33921479)
1. Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers.
Basok SS; Schepetkin IA; Khlebnikov AI; Lutsyuk AF; Kirichenko TI; Kirpotina LN; Pavlovsky VI; Leonov KA; Vishenkova DA; Quinn MT
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921479
[TBL] [Abstract][Full Text] [Related]
2. Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes.
Arenaza-Corona A; Couce-Fortúnez MD; de Blas A; Morales-Morales D; Santillan R; Höpfl H; Rodríguez-Blas T; Barba V
Inorg Chem; 2020 Oct; 59(20):15120-15134. PubMed ID: 33000942
[TBL] [Abstract][Full Text] [Related]
3. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
[TBL] [Abstract][Full Text] [Related]
5. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
[TBL] [Abstract][Full Text] [Related]
6. Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
Supek F; Ramljak TŠ; Marjanović M; Buljubašić M; Kragol G; Ilić N; Smuc T; Zahradka D; Mlinarić-Majerski K; Kralj M
Eur J Med Chem; 2011 Aug; 46(8):3444-54. PubMed ID: 21628081
[TBL] [Abstract][Full Text] [Related]
7. Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores.
Marjanović M; Kralj M; Supek F; Frkanec L; Piantanida I; Smuc T; Tusek-Bozić L
J Med Chem; 2007 Mar; 50(5):1007-18. PubMed ID: 17300184
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Human Neutrophil Responses by the Essential Oil of Artemisia kotuchovii and Its Constituents.
Schepetkin IA; Kushnarenko SV; Özek G; Kirpotina LN; Utegenova GA; Kotukhov YA; Danilova AN; Özek T; Başer KH; Quinn MT
J Agric Food Chem; 2015 May; 63(20):4999-5007. PubMed ID: 25959257
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of aza-crown ether-squaramide conjugates as anion/cation symporters.
Yu XH; Cai XJ; Hong XQ; Tam KY; Zhang K; Chen WH
Future Med Chem; 2019 May; 11(10):1091-1106. PubMed ID: 31280669
[No Abstract] [Full Text] [Related]
10. Stabilizing divalent europium in aqueous solution using size-discrimination and electrostatic effects.
Regueiro-Figueroa M; Barriada JL; Pallier A; Esteban-Gómez D; Blas Ad; Rodríguez-Blas T; Tóth É; Platas-Iglesias C
Inorg Chem; 2015 May; 54(10):4940-52. PubMed ID: 25942280
[TBL] [Abstract][Full Text] [Related]
11. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.
Kirpotina LN; Khlebnikov AI; Schepetkin IA; Ye RD; Rabiet MJ; Jutila MA; Quinn MT
Mol Pharmacol; 2010 Feb; 77(2):159-70. PubMed ID: 19903830
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
[TBL] [Abstract][Full Text] [Related]
14. DFT study of the carbon- and nitrogen-pivot lariat crown ethers and their complexes with alkali metal cations: Na(+), K(+).
Zheng X; Wang X; Yi S; Wang N; Peng Y
J Comput Chem; 2009 Dec; 30(16):2674-83. PubMed ID: 19399776
[TBL] [Abstract][Full Text] [Related]
15. Development of the aza-crown ether metal complexes as artificial hydrolase.
Yu L; Li FZ; Wu JY; Xie JQ; Li S
J Inorg Biochem; 2016 Jan; 154():89-102. PubMed ID: 26460062
[TBL] [Abstract][Full Text] [Related]
16. Convenient approaches to synthesis of furanoid sugar-aza-crown ethers from C-ribosyl azido aldehyde via a reductive amination/amidation.
Hsieh YC; Chir JL; Zou W; Wu HH; Wu AT
Carbohydr Res; 2009 May; 344(8):1020-3. PubMed ID: 19362710
[TBL] [Abstract][Full Text] [Related]
17. DFT study of glucose based glycolipid crown ethers and their complexes with alkali metal cations Na(+) and K(+).
Nguan H; Ahmadi S; Hashim R
J Mol Model; 2012 Dec; 18(12):5041-50. PubMed ID: 22752540
[TBL] [Abstract][Full Text] [Related]
18. Designing binuclear transition metal complexes: a new example of the versatility of N,N'-bis(2-aminobenzyl)-4,13-diaza-18-crown-6.
Vaiana L; Platas-Iglesias C; Esteban-Gómez D; Avecilla F; Clemente-Juan JM; Real JA; de Blas A; Rodríguez-Blas T
Dalton Trans; 2005 Jun; (11):2031-7. PubMed ID: 15909055
[TBL] [Abstract][Full Text] [Related]
19. 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Leopoldo M; Lucente E; Lacivita E; De Giorgio P; Quinn MT
Biochem Pharmacol; 2013 Feb; 85(3):404-16. PubMed ID: 23219934
[TBL] [Abstract][Full Text] [Related]
20. Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.
Giovannoni MP; Schepetkin IA; Cilibrizzi A; Crocetti L; Khlebnikov AI; Dahlgren C; Graziano A; Dal Piaz V; Kirpotina LN; Zerbinati S; Vergelli C; Quinn MT
Eur J Med Chem; 2013 Jun; 64():512-28. PubMed ID: 23685570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
